Boosters Won't Make It To Everyone For Now, But Vaccines For Young Children Are Coming
Consider This from NPR
00:00
Urgency and Safety in the Race for Pediatric Vaccine Approval
This chapter explores the push for FDA authorization of a COVID-19 vaccine for children aged 5 to 11, emphasizing trial safety and effectiveness. It also examines the challenges of balancing urgent public health needs with the necessity for thorough evaluation.
Play episode from 05:20
Transcript
